Dan Henry, MD
Family Medicine · Slc, UTNPI 1871528018
Payments from drug & device makers
Across 760 payments — averaging $905.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$282K
- AbbVie$224K
- H. Lundbeck A S$95K
- Eli Lilly$41K
- Lundbeck LLC$26K
- Amgen$17K
- plus $1K from 24 others
Across 2 payments — averaging $5548.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$11K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 412 | $282,359 |
| AbbVie(2 entities) | 216 | $224,392 |
| H. Lundbeck A S | 18 | $95,263 |
| Eli Lilly | 4 | $41,474 |
| Lundbeck LLC | 15 | $25,734 |
| Amgen | 21 | $17,292 |
| Upsher-smith Laboratories LLC | 20 | $265 |
| Biohaven Pharmaceuticals, Inc. | 8 | $225 |
| Pfizer | 9 | $148 |
| Abbott | 5 | $118 |
| Merck | 3 | $74 |
| Scilex Pharmaceuticals Inc. | 3 | $60 |
| Boston Scientific | 3 | $54 |
| Supernus Pharmaceuticals, Inc. | 3 | $52 |
| Lucid Diagnostics Inc. | 1 | $51 |
| Axsome Therapeutics, Inc. | 2 | $50 |
| GSK | 3 | $47 |
| Novo Nordisk | 2 | $24 |
| Novartis | 1 | $20 |
| Alkermes, Inc. | 1 | $18 |
| Amarin Pharma, Inc. | 1 | $17 |
| Sonex Health, Inc. | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Nevro Corp. | 1 | $16 |
| Astellas Pharma US Inc | 1 | $15 |
| Assertio Therapeutics, Inc. | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
| Medtronic | 1 | $13 |
| Impel Pharmaceuticals Inc. | 1 | $12 |
| Mayne Pharma Commercial LLC | 1 | $6 |
How this compares
$687,859 in reported general payments places this provider in the 95th percentile of 928 family medicine providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family medicine in Slc
- John HemmersmeierOgden$24.9M
- Judith KirsteinWest Jordan$22.7M
- Matthew JohnstonSalt Lake City$20.9M
- Jared ProbstSalt Lake City$18.8M
- Bryce PetersonBountiful$16M
- Sarang YoonSalt Lake City$9.4M
- Michael AdamsSandy$8.1M
- Katie JulienSouth Jordan$7.1M
- Scott EricksonBountiful$3.7M
- John RichardsSouth Jordan$2.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.